BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30066351)

  • 1. Pre- and post-magnetic resonance imaging features of suspicious internal mammary lymph nodes in breast cancer patients receiving neo-adjuvant therapy: Are any imaging features predictive of malignancy?
    Patel S; Delikat A; Liao J; Chetlen AL
    Breast J; 2018 Nov; 24(6):997-1000. PubMed ID: 30066351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internal mammary lymph node metastases in breast cancer: what should radiologists know?
    Urano M; Denewar FA; Murai T; Mizutani M; Kitase M; Ohashi K; Shiraki N; Shibamoto Y
    Jpn J Radiol; 2018 Nov; 36(11):629-640. PubMed ID: 30194586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental Internal Mammary Lymph Nodes Visualized on Screening Breast MRI.
    Mack M; Chetlen A; Liao J
    AJR Am J Roentgenol; 2015 Jul; 205(1):209-14. PubMed ID: 26102401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy of MRI-detected involved internal mammary lymph nodes in breast cancer.
    Sachdev S; Goodman CR; Neuschler E; Kalakota K; Cutright D; Donnelly ED; Hayes JP; Prescott AE; Mirabelli G; Strauss JB
    Radiat Oncol; 2017 Dec; 12(1):199. PubMed ID: 29258542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence and risk factors of internal mammary lymph nodes metastases in breast cancer patients].
    Wang W; Li JB
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):801-804. PubMed ID: 31770845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
    van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
    Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.
    Beek MA; Tetteroo E; Luiten EJ; Gobardhan PD; Rutten HJ; Heijns JB; Voogd AC; Klompenhouwer EG
    Eur J Surg Oncol; 2016 May; 42(5):672-8. PubMed ID: 26898838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of breast ultrasonography and MRI in the prediction of lymph node status after neoadjuvant chemotherapy for breast cancer.
    Ha SM; Cha JH; Kim HH; Shin HJ; Chae EY; Choi WJ
    Acta Radiol; 2017 Oct; 58(10):1198-1205. PubMed ID: 28350255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pictorial Review of Sonography of Intramammary Lymph Nodes: When to Care and What to Do About It.
    Hudspeth TN; Shin K; Babiera GV; Krishnamurthy S; Woodtichartpreecha P; Karbasian N; Whitman GJ
    Ultrasound Q; 2019 Mar; 35(1):74-78. PubMed ID: 30516732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional imaging to evaluate the extent of regional nodal disease in breast cancer patients undergoing neoadjuvant systemic therapy.
    Anderson TL; Glazebrook KN; Murphy BL; Viers LD; Hieken TJ
    Eur J Radiol; 2017 Apr; 89():163-168. PubMed ID: 28267534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retrosternal lymph node metastases in breast cancer: lymphoscintigraphy and magnetic resonance tomography].
    Linden A; Reusch K; Smolarz K; Jungehülsing M; Theissen P; Bolte A; Schicha H
    Nuklearmedizin; 1991 Dec; 30(6):279-82. PubMed ID: 1780241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stage migration after biopsy of internal mammary sentinel lymph node in breast cancer patient].
    Deliĭski T
    Khirurgiia (Sofiia); 2005; (2):26-7. PubMed ID: 18681144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiological imaging features of invasive micropapillary carcinoma of the breast and axillary lymph nodes.
    Kubota K; Ogawa Y; Nishioka A; Murata Y; Itoh S; Hamada N; Morio K; Maeda H; Tanaka Y
    Oncol Rep; 2008 Nov; 20(5):1143-7. PubMed ID: 18949414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma.
    Ulaner GA; Healey JH; Athanasian EA
    Clin Orthop Relat Res; 2017 Sep; 475(9):2274-2279. PubMed ID: 28536856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients.
    Heuts EM; van der Ent FW; von Meyenfeldt MF; Voogd AC
    Eur J Surg Oncol; 2009 Mar; 35(3):252-7. PubMed ID: 18684584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltration tendency of internal mammary lymph nodes involvement in patients with breast cancer: anatomical characteristics and implications for target delineation.
    Wang Y; Qi W; Xu H; Zhang M; Han Y; Chen J; Xu C
    Radiat Oncol; 2019 Nov; 14(1):208. PubMed ID: 31752910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thin-section CT evaluation and pathologic correlation of therapeutic effect of neoadjuvant chemotherapy for axillary lymph nodes of clinically node-positive breast cancer patients.
    Ogawa Y; Nishioka A; Nishigawa T; Kubota K; Kariya S; Yoshida S; Tanaka Y; Moriki T; Tochika N
    Oncol Rep; 2003; 10(4):985-9. PubMed ID: 12792757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of internal mammary lymph node (IMLN) biopsy during autologous reconstruction in breast cancer patients.
    Zhang X; Jaffer S; Bleiweiss IJ; Nayak A
    Breast Cancer Res Treat; 2015 Oct; 153(3):565-72. PubMed ID: 26358711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
    Aukema TS; Straver ME; Peeters MJ; Russell NS; Gilhuijs KG; Vogel WV; Rutgers EJ; Olmos RA
    Eur J Cancer; 2010 Dec; 46(18):3205-10. PubMed ID: 20719497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.